Literature DB >> 33770312

Call to action: breast cancer screening recommendations for Black women.

Bridget A Oppong1, Samilia Obeng-Gyasi2, Theresa Relation2, Lucile Adams-Campbell3.   

Abstract

African-American/Black women have more aggressive breast cancer subtypes, are diagnosed at younger ages, and have an increasing incidence rate. These disparities have resulted in Black women continuing to experience the highest mortality rate from breast cancer of any US racial or ethnic group. However, national screening mammography guidelines do not reflect the high-risk status of Black women. Here we review breast cancer screening guidelines and address the lack of inclusion of the specific needs of Black women. In order to equitably care for the health needs of Black women, high-risk designation would improve access to earlier screening and supplemental imaging including breast MRI.

Entities:  

Keywords:  Black women; Breast cancer; Mammography; Screening

Year:  2021        PMID: 33770312     DOI: 10.1007/s10549-021-06207-6

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  5 in total

Review 1.  Triple-negative breast cancer in African-American women: disparities versus biology.

Authors:  Eric C Dietze; Christopher Sistrunk; Gustavo Miranda-Carboni; Ruth O'Regan; Victoria L Seewaldt
Journal:  Nat Rev Cancer       Date:  2015-02-12       Impact factor: 60.716

Review 2.  Understanding and effectively addressing breast cancer in African American women: Unpacking the social context.

Authors:  David R Williams; Selina A Mohammed; Alexandra E Shields
Journal:  Cancer       Date:  2016-02-29       Impact factor: 6.860

3.  Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State.

Authors:  Betsy A Kohler; Recinda L Sherman; Nadia Howlader; Ahmedin Jemal; A Blythe Ryerson; Kevin A Henry; Francis P Boscoe; Kathleen A Cronin; Andrew Lake; Anne-Michelle Noone; S Jane Henley; Christie R Eheman; Robert N Anderson; Lynne Penberthy
Journal:  J Natl Cancer Inst       Date:  2015-03-30       Impact factor: 13.506

Review 4.  Racial Disparity and Triple-Negative Breast Cancer in African-American Women: A Multifaceted Affair between Obesity, Biology, and Socioeconomic Determinants.

Authors:  Sumit Siddharth; Dipali Sharma
Journal:  Cancers (Basel)       Date:  2018-12-14       Impact factor: 6.639

5.  Hold your breath - Differential behavioral and sensory acuity of mosquitoes to acetone and carbon dioxide.

Authors:  Majid Ghaninia; Shahid Majeed; Teun Dekker; Sharon R Hill; Rickard Ignell
Journal:  PLoS One       Date:  2019-12-30       Impact factor: 3.240

  5 in total
  4 in total

Review 1.  The Landmark Series-Addressing Disparities in Breast Cancer Screening: New Recommendations for Black Women.

Authors:  Oluwadamilola M Fayanju; Christine E Edmonds; Sylvia A Reyes; Cletus Arciero; Vivian J Bea; Angelena Crown; Kathie-Ann Joseph
Journal:  Ann Surg Oncol       Date:  2022-10-03       Impact factor: 4.339

2.  Perioperative magnetic resonance imaging in breast cancer care: Distinct adoption trajectories among physician patient-sharing networks.

Authors:  Xiao Xu; Pamela R Soulos; Jeph Herrin; Shi-Yi Wang; Craig Evan Pollack; Brigid K Killelea; Howard P Forman; Cary P Gross
Journal:  PLoS One       Date:  2022-03-15       Impact factor: 3.240

3.  The Impact of Organised Screening Programs on Breast Cancer Stage at Diagnosis for Canadian Women Aged 40-49 and 50-59.

Authors:  Anna N Wilkinson; Jean-Michel Billette; Larry F Ellison; Michael A Killip; Nayaar Islam; Jean M Seely
Journal:  Curr Oncol       Date:  2022-08-09       Impact factor: 3.109

4.  Barriers to breast cancer screening in Atlanta, GA: results from the Pink Panel survey at faith-based institutions.

Authors:  Adelaide Balenger; Gaurav Seth; Shristi Bhattarai; Lindsay J Collin; Lauren McCullough; Keerthi Gogineni; Preeti Subhedar; Calvin Ellison; Uzma Khan; Monica H Swahn; Ritu Aneja
Journal:  Cancer Causes Control       Date:  2022-09-26       Impact factor: 2.532

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.